Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:20870719rdf:typepubmed:Citationlld:pubmed
pubmed-article:20870719lifeskim:mentionsumls-concept:C0079427lld:lifeskim
pubmed-article:20870719lifeskim:mentionsumls-concept:C0035335lld:lifeskim
pubmed-article:20870719lifeskim:mentionsumls-concept:C1325410lld:lifeskim
pubmed-article:20870719lifeskim:mentionsumls-concept:C0025723lld:lifeskim
pubmed-article:20870719lifeskim:mentionsumls-concept:C1427221lld:lifeskim
pubmed-article:20870719pubmed:issue48lld:pubmed
pubmed-article:20870719pubmed:dateCreated2010-11-24lld:pubmed
pubmed-article:20870719pubmed:abstractTextThe retinoblastoma tumor suppressor (RB) is a central cell cycle regulator and tumor suppressor. RB cellular functions are known to be regulated by a diversity of post-translational modifications such as phosphorylation and acetylation, raising the possibility that RB may also be methylated in cells. Here we demonstrate that RB can be methylated by SMYD2 at lysine 860, a highly conserved and novel site of modification. This methylation event occurs in vitro and in cells, and it is regulated during cell cycle progression, cellular differentiation, and in response to DNA damage. Furthermore, we show that RB monomethylation at lysine 860 provides a direct binding site for the methyl-binding domain of the transcriptional repressor L3MBTL1. These results support the idea that a code of post-translational modifications exists for RB and helps guide its functions in mammalian cells.lld:pubmed
pubmed-article:20870719pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20870719pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20870719pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20870719pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20870719pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20870719pubmed:languageenglld:pubmed
pubmed-article:20870719pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20870719pubmed:citationSubsetIMlld:pubmed
pubmed-article:20870719pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20870719pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20870719pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20870719pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20870719pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20870719pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20870719pubmed:statusMEDLINElld:pubmed
pubmed-article:20870719pubmed:monthNovlld:pubmed
pubmed-article:20870719pubmed:issn1083-351Xlld:pubmed
pubmed-article:20870719pubmed:authorpubmed-author:SageJulienJlld:pubmed
pubmed-article:20870719pubmed:authorpubmed-author:YatesJohn...lld:pubmed
pubmed-article:20870719pubmed:authorpubmed-author:GozaniOrOlld:pubmed
pubmed-article:20870719pubmed:authorpubmed-author:RubinSeth MSMlld:pubmed
pubmed-article:20870719pubmed:authorpubmed-author:AslanianAaron...lld:pubmed
pubmed-article:20870719pubmed:authorpubmed-author:SaddicLouis...lld:pubmed
pubmed-article:20870719pubmed:authorpubmed-author:WestLisandra...lld:pubmed
pubmed-article:20870719pubmed:issnTypeElectroniclld:pubmed
pubmed-article:20870719pubmed:day26lld:pubmed
pubmed-article:20870719pubmed:volume285lld:pubmed
pubmed-article:20870719pubmed:ownerNLMlld:pubmed
pubmed-article:20870719pubmed:authorsCompleteYlld:pubmed
pubmed-article:20870719pubmed:pagination37733-40lld:pubmed
pubmed-article:20870719pubmed:dateRevised2011-4-6lld:pubmed
pubmed-article:20870719pubmed:meshHeadingpubmed-meshheading:20870719...lld:pubmed
pubmed-article:20870719pubmed:meshHeadingpubmed-meshheading:20870719...lld:pubmed
pubmed-article:20870719pubmed:meshHeadingpubmed-meshheading:20870719...lld:pubmed
pubmed-article:20870719pubmed:meshHeadingpubmed-meshheading:20870719...lld:pubmed
pubmed-article:20870719pubmed:meshHeadingpubmed-meshheading:20870719...lld:pubmed
pubmed-article:20870719pubmed:meshHeadingpubmed-meshheading:20870719...lld:pubmed
pubmed-article:20870719pubmed:meshHeadingpubmed-meshheading:20870719...lld:pubmed
pubmed-article:20870719pubmed:meshHeadingpubmed-meshheading:20870719...lld:pubmed
pubmed-article:20870719pubmed:meshHeadingpubmed-meshheading:20870719...lld:pubmed
pubmed-article:20870719pubmed:meshHeadingpubmed-meshheading:20870719...lld:pubmed
pubmed-article:20870719pubmed:meshHeadingpubmed-meshheading:20870719...lld:pubmed
pubmed-article:20870719pubmed:meshHeadingpubmed-meshheading:20870719...lld:pubmed
pubmed-article:20870719pubmed:meshHeadingpubmed-meshheading:20870719...lld:pubmed
pubmed-article:20870719pubmed:year2010lld:pubmed
pubmed-article:20870719pubmed:articleTitleMethylation of the retinoblastoma tumor suppressor by SMYD2.lld:pubmed
pubmed-article:20870719pubmed:affiliationDepartments of Pediatrics, Stanford University, Stanford, California 94305, USA.lld:pubmed
pubmed-article:20870719pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:20870719pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:20870719pubmed:publicationTypeResearch Support, N.I.H., Extramurallld:pubmed
entrez-gene:5925entrezgene:pubmedpubmed-article:20870719lld:entrezgene
entrez-gene:56950entrezgene:pubmedpubmed-article:20870719lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:20870719lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:20870719lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:20870719lld:entrezgene